Industrial, Manufacturing & Heavy Industry Market News

In vitro toxicology testing market worth 8.74 billion USD by 2022 according to new research report

In vitro toxicology testing market worth 8.74 billion USD by 2022 according to new research report

The in vitro toxicology testing market is expected to reach USD 8.74 Billion by 2022 from an estimated USD 6.34 Billion in 2017, at a CAGR of 6.6%

- Advertising -

The report "In Vitro Toxicology Testing Market by Products (Assays) & Services, Toxicity Endpoints & Tests (ADME, Skin, Genotoxicity, Organ Toxicity), Technology (Cell-based, HTS), Method (Cellular Assays, Ex-Vivo), Industry (Pharmaceutical, Cosmetics) - Forecast to 2022", The key factors driving the growth of this market include opposition to animal testing, growing demand for in vitro technology in the European market, new and promising technologies, and increasing R&D expenditure to detect toxicity at an early stage.

Browse 139 Market Data Tables and 32 Figures spread through 253 Pages and in-depth TOC on "In Vitro Toxicology Testing Market"
www.marketsandmarkets.com/Market-R…et-209577065.html

By Toxicity Endpoints and Tests, ADME hold the largest market share in 2017

Based on toxicity endpoints and tests of in vitro toxicology testing, the market is subsegmented into ADME, genotoxicity, skin irritation and sensitization, cytotoxicity, ocular toxicity, organ toxicity, phototoxicity, dermal toxicity, and other toxicities (eco toxicity, endocrine disruption, and reproductive & developmental toxicity). In 2017, the ADME segment is expected to account for the largest share of the global in vitro toxicology testing market owing to its highly reproducible & accurate data and the increasing demand to curb drug toxicity at the drug development phase.

- Advertising -

Download PDF Brochure: -www.marketsandmarkets.com/pdfdownload.asp?id=209577065

Cell culture technology to hold the largest market share in 2017

Based on technology, the in vitro toxicology testing market is segmented into cell culture technologies, high-throughput technologies, cellular imaging technologies, and toxicogenomics. The toxicogenomics segment is expected to account for the highest CAGR in the global in the vitro toxicology testing market.

Toxicogenomics is preferred to elucidate the changes in gene expression in response to toxic exposure and facilitates to identify toxicity pathways.

Download Sample Pages:- www.marketsandmarkets.com/requests….asp?id=209577065

US expected to hold the largest share of the in vitro toxicology testing market in 2017

US is estimated to account for the largest share among other regions in the in vitro toxicology testing market, followed by Germany and UK. In the Asia Pacific region, China is expected to grow at the highest CAGR during the forecast period.

The major players in the global in vitro toxicology testing market include Cyprotex  (An Evotec AG subsidiary, Germany), Covance (A Laboratory Corporations of America Holding’s subsidiary, US), Eurofins Scientific SE (Luxembourg), GE Healthcare (US), Thermo Fisher Scientific (US), SGS SA (Switzerland), Promega Corporation (US), Merck KGaA (Germany), Charles River Laboratories, Inc. (US), and Lonza Group Ltd. (Switzerland), among others.

 

News From

MarketsandMarkets™ - Business ResearchMarketsandMarkets™
Category: Market Research Publishers and RetailersCompany profile: MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions. Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth ...